Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

Share Price is delayed by 15 minutes
Get Live Data
165.00    0.00 (0.00%)
Bid:
140.00
Ask:
190.00
Spread: 50.00 (35.714%)
Market Cap: £3.56m
ATY Live PriceLast checked at - London Stock Exchange

Intraday Athelney Tst. Share Chart

Net Asset Value(s)

5 Feb 2025 08:01

RNS Number : 0049W
Athelney Trust PLC
05 February 2025
 

 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 189.4p at 31 January 2025.

Fund Manager's comment for January 2025

In the US, the Federal Reserve kept the fed funds rate steady at the 4.25%-4.5% range during its January 2025 meeting, in line with expectations. Policymakers noted that recent indicators suggest that economic activity has continued to expand at a solid pace. The unemployment rate has stabilized at 4.1%, and labour market conditions remain solid. The U.S. economy expanded at a 2.3% annualized rate in Q4, bringing the annual growth rate to 2.8% in 2024. Growth was held back by a slower stockpiling in inventories, but boosted by solid consumer spending, both of which may partially reflect a pull forward in demand ahead of potential tariffs.

The US Manufacturing PMI edged up in January and signalled a slight improvement in manufacturing conditions after six months of decline. Factory production rose marginally for the first time in 6 months, with new orders also returning to modest growth. The Services PMI fell in January missing market expectations to mark the softest pace of expansion in US manufacturing activity since April of last year.

In the Eurozone, the economy unexpectedly stagnated in Q4, marking its weakest performance of the year after 0.4% growth in Q3. Unemployment rose slightly to 6.3% in December. The ECB cut interest rates by 25 bps in January as expected, reflecting easing inflation pressures. This move reflects the ECB's updated inflation outlook, with price pressures easing in line with projections. The Services PMI declined slightly, missing expectations, though activity remained in expansion. Meanwhile, the Manufacturing PMI surpassed forecasts, with optimism reaching a seven-month high.

In the UK, the Bank of England kept interest rates at 4.75% in December, citing inflation risks from rising wages and price pressures. The UK economy stalled in Q3 2024, with growth revised down from earlier estimates with unemployment rising to 4.4% between September and November. The Services PMI edged higher in January but showed only slight business activity growth, while new orders declined for the first time in 15 months. Employment continued to fall due to rising staff costs, and inflationary pressures persisted, driven by wages and energy costs. Business sentiment remained pessimistic.

The UK Manufacturing PMI rose slightly in January from December's 11-month low but continued to indicate worsening conditions. Output contracted for the third consecutive month, and new orders declined, reflecting weak domestic and overseas demand. Employment in Manufacturing fell in January, with job losses accelerating. Inflationary pressures intensified, with input costs and output charges rising at the fastest pace in two years.

Global equity markets remained strong in January. The MSCI World Index gained 3.93%, the S&P 500 rose by 2.7% and the Nasdaq gained 1.64%. In the UK, the FTSE 100 reached a new all-time high rising 6.13%, the best month in more than two years. Smaller companies were mixed with the FTSE 250 rising 1.59%, the Small Cap Index rising 0.07% and the Fledgling Index up 1.11%. The AIM All-Share Index struggled however and was down by 0.21%.

Our portfolio performed well during the month, up by 2.59% with the net asset value (NAV) increasing by 1.77% after accounting for all expenses. Notable contributors to performance included 4Imprint, Raspberry Pi, S&U Plc and Alpha Group, each gaining over 10% during the month. We reduced our holdings in Cerillion Plc and at month-end cash holdings comprised 3.2% of the portfolio.

 

 

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "About" then select "Latest Monthly Fact Sheet".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (license no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has AUD2.7bn (£1.5 billion) under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

AUD95m https://flagshipinvestments.com.au

· Barrack St Investments (ASX code: BST)

AUD37m www.barrackst.com

· Global Masters Fund Limited (ASX code: GFL)

AUD33m www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

GBP6m www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is a "Dividend Hero" being one of only a few investment companies that have increased their dividend every year for 20 years or more. See link

https://www.theaic.co.uk/income-finder/dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVGIGDDBGGDGUU
Date   Source Headline
4th Jul 20238:50 amRNSNet Asset Value(s)
5th Jun 20237:28 amRNSNet Asset Value(s)
3rd May 202310:14 amRNSNet Asset Value(s)
4th Apr 202312:05 pmRNSNet Asset Value(s)
17th Mar 20231:15 pmRNSResult of AGM
2nd Mar 202312:39 pmRNSNet Asset Value(s)
13th Feb 20236:02 pmRNSAnnual Financial Report
2nd Feb 20237:00 amRNSNet Asset Value(s)
9th Jan 202310:11 amRNSNet Asset Value(s)
5th Dec 20227:51 amRNSNet Asset Value(s)
2nd Nov 20227:50 amRNSNet Asset Value(s)
4th Oct 20229:02 amRNSNet Asset Value(s)
5th Sep 20227:09 amRNSNet Asset Value(s)
2nd Aug 202211:57 amRNSNet Asset Value(s)
26th Jul 202212:44 pmRNSHalf-year Report
4th Jul 20229:13 amRNSNet Asset Value(s)
6th Jun 20229:36 amRNSNet Asset Value(s)
4th May 20227:56 amRNSNet Asset Value(s)
5th Apr 20223:10 pmRNSAGM Statement
4th Apr 20229:55 amRNSNet Asset Value(s)
2nd Mar 202211:33 amRNSNet Asset Value(s)
23rd Feb 20221:13 pmRNSAnnual Financial Report
2nd Feb 20229:05 amRNSNet Asset Value(s)
12th Jan 20225:03 pmRNSHolding(s) in Company
12th Jan 20225:00 pmRNSHolding(s) in Company
12th Jan 20225:00 pmRNSHolding(s) in Company
5th Jan 20228:14 amRNSNet Asset Value(s)
3rd Dec 202112:00 pmRNSNet Asset Value(s)
2nd Nov 20218:12 amRNSNet Asset Value(s)
4th Oct 202111:40 amRNSNet Asset Value(s)
2nd Sep 202111:44 amRNSNet Asset Value(s)
3rd Aug 20211:18 pmRNSNet Asset Value(s)
27th Jul 202111:20 amRNSHalf-year Report
2nd Jul 20218:32 amRNSNet Asset Value(s)
3rd Jun 20218:19 amRNSNet Asset Value(s)
5th May 20219:19 amRNSNet Asset Value(s)
15th Apr 20219:48 amRNSMajor shareholding notification
15th Apr 20219:46 amRNSMajor shareholder notification
6th Apr 202110:01 amRNSNet Asset Value(s)
30th Mar 20211:20 pmRNSResult of AGM
2nd Mar 202110:11 amRNSNet Asset Value(s)
24th Feb 202112:54 pmRNSAnnual Financial Report
2nd Feb 20219:55 amRNSNet Asset Value(s)
5th Jan 202112:01 pmRNSNet Asset Value(s)
2nd Dec 202012:22 pmRNSNet Asset Value(s)
3rd Nov 20209:30 amRNSNet Asset Value(s)
12th Oct 20209:43 amRNSDirector Declaration
2nd Oct 202011:05 amRNSNet Asset Value(s)
3rd Sep 202010:49 amRNSNet Asset Value(s)
4th Aug 20209:25 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.